decisionhealth Newsletters, Coder Pink Sheets - 2008 Issue 10 (October)
Now there is a C-code for Lexiscan, but not for physician office use
Subscribe or sign in to view the full article.
Article Overview
This article explains a Medicare coding update affecting regadenoson (Lexiscan) and discusses how its HCPCS status differs between the hospital outpatient setting and physician office use. It is relevant to nuclear medicine, cardiology, and medical billing staff who need to understand the timing and setting limitations associated with the code change and the related manufacturer and CMS application plans.
Why This Topic Matters
It helps readers track a small but important HCPCS update that affects how a commonly used pharmacologic stress agent is reported in different outpatient settings.
What You Will Learn
- The difference between hospital outpatient and physician office billing implications for a Lexiscan-related HCPCS update.
- How CMS and the manufacturer are described as handling temporary and future coding changes.
- The general context of coding for pharmacologic stress testing in nuclear medicine.
- The timing referenced for the code update and related application cycle.
Who Should Read This
- Medical coders
- Billing staff
- Cardiology practices
- Nuclear medicine professionals
- Compliance staff
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com